PD-1 inhibitor (anti-PD-1 immunotherapy)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PD-1 inhibitor (anti-PD-1 immunotherapy), covering 2025-04-04 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]